323 related articles for article (PubMed ID: 29082111)
1. Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.
Habiel DM; Hogaboam CM
Curr Pathobiol Rep; 2017 Jun; 5(2):101-110. PubMed ID: 29082111
[TBL] [Abstract][Full Text] [Related]
2. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.
Humphreys BD; Lin SL; Kobayashi A; Hudson TE; Nowlin BT; Bonventre JV; Valerius MT; McMahon AP; Duffield JS
Am J Pathol; 2010 Jan; 176(1):85-97. PubMed ID: 20008127
[TBL] [Abstract][Full Text] [Related]
3. Origins of pathological myofibroblasts in lung fibrosis: insights from lineage tracing mouse models in the single-cell RNA sequencing era.
Homps-Legrand M; Crestani B; Mailleux AA
Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L737-L746. PubMed ID: 36976924
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
5. NO-sensitive guanylyl cyclase discriminates pericyte-derived interstitial from intra-alveolar myofibroblasts in murine pulmonary fibrosis.
Aue A; Englert N; Harrer L; Schwiering F; Gaab A; König P; Adams R; Schmidtko A; Friebe A; Groneberg D
Respir Res; 2023 Jun; 24(1):167. PubMed ID: 37349733
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis.
Ligresti G; Raslan AA; Hong J; Caporarello N; Confalonieri M; Huang SK
Gene; 2023 Apr; 859():147142. PubMed ID: 36603696
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk.
Hill C; Jones MG; Davies DE; Wang Y
J Lung Health Dis; 2019 Apr; 3(2):31-35. PubMed ID: 31032489
[TBL] [Abstract][Full Text] [Related]
9. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.
Rock JR; Barkauskas CE; Cronce MJ; Xue Y; Harris JR; Liang J; Noble PW; Hogan BL
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):E1475-83. PubMed ID: 22123957
[TBL] [Abstract][Full Text] [Related]
10. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
Pardo A; Selman M
Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
[TBL] [Abstract][Full Text] [Related]
11. Resident interstitial lung fibroblasts and their role in alveolar stem cell niche development, homeostasis, injury, and regeneration.
Ushakumary MG; Riccetti M; Perl AT
Stem Cells Transl Med; 2021 Jul; 10(7):1021-1032. PubMed ID: 33624948
[TBL] [Abstract][Full Text] [Related]
12. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis.
Habiel DM; Hogaboam C
Front Pharmacol; 2014; 5():2. PubMed ID: 24478703
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast.
Gharaee-Kermani M; Hu B; Phan SH; Gyetko MR
Curr Med Chem; 2009; 16(11):1400-17. PubMed ID: 19355895
[TBL] [Abstract][Full Text] [Related]
16. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.
Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA
Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067
[TBL] [Abstract][Full Text] [Related]
17. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
18. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis.
Tanjore H; Xu XC; Polosukhin VV; Degryse AL; Li B; Han W; Sherrill TP; Plieth D; Neilson EG; Blackwell TS; Lawson WE
Am J Respir Crit Care Med; 2009 Oct; 180(7):657-65. PubMed ID: 19556518
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis.
Gan H; McKenzie R; Hao Q; Idell S; Tang H
PLoS One; 2014; 9(7):e101983. PubMed ID: 25000413
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleus chromatin accessibility identifies a critical role for TWIST1 in idiopathic pulmonary fibrosis myofibroblast activity.
Valenzi E; Bahudhanapati H; Tan J; Tabib T; Sullivan DI; Nouraie M; Sembrat J; Fan L; Chen K; Liu S; Rojas M; Lafargue A; Felsher DW; Tran PT; Kass DJ; Lafyatis R
Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37142338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
